Farther Finance Advisors’s Neuropace NPCE Stock Holding History

Farther Finance Advisors’s Portfolio NPCE Stock Details NPCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$399	Buy	25 +15	+150%	+$241	﹤0.01%	5576
2026 Q1	$141	Buy	+10	New	+$150	﹤0.01%	5476

Other funds holding NPCE

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

HFS

Hughes Financial Services Herndon, Virginia $755M AUM 20.43% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Farther Finance Advisors's NPCE Position: Q2 2026 in Review

Farther Finance Advisors increased its Neuropace (NPCE) stake by 150% in Q2 2026, buying an estimated $241 and bringing the position to 25 shares worth $399. The position accounts for ﹤0.01% of the portfolio, ranked #5576.

Farther Finance Advisors first reported a position in NPCE in Q1 2026 and has held it in 2 quarters since. 4 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

Farther Finance Advisors held 25 shares of Neuropace worth $399 as of Q2 2026.
Farther Finance Advisors bought 15 Neuropace shares in Q2 2026, an estimated $241.
Neuropace made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5576 holding.
Farther Finance Advisors first reported a position in Neuropace in Q1 2026 and has held it in 2 quarters since.
4 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.